Geisinger Medical Center
- Type
- Teaching hospital
- Where
- DANVILLE, PA
- Medicare CCN
- 390006
- Received
- $740,614 in 146 records, 2020 ($137,121 general, $603,493 research)
- Source
- CMS Open Payments search ↗
On this site
- Business registration: Geisinger Medical Center Fuzzy (name and state)
- Business registration: Geisinger Medical Center Fuzzy (name and state)
- Business registration: Geisinger Medical Center Fuzzy (name and state)
- Business registration: GEISINGER MEDICAL CENTER Fuzzy (name and state)
- Business registration: GEISINGER MEDICAL CENTER Fuzzy (name and state)
- Business registration: GEISINGER MEDICAL CENTER, INC. Fuzzy (name and state)
- Nonprofit contractor: GEISINGER MEDICAL CENTER Fuzzy (name and state)
- Nonprofit: GEISINGER MEDICAL CENTER Fuzzy (name and state)
- Trademark owner: Geisinger Medical Center Fuzzy (name and state)
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2020 | General payment | 82 | $137,121 |
| 2020 | Research payment | 64 | $603,493 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Novo Nordisk Inc | 5 | $325,306 | 2020 |
| JAZZ PHARMACEUTICALS INC. | 5 | $102,250 | 2020 |
| OpGen, Inc. | 1 | $44,275 | 2020 |
| Novo Nordisk AS | 13 | $39,829 | 2020 |
| CSL Behring | 21 | $38,044 | 2020 |
| Merck Sharp & Dohme LLC | 12 | $32,974 | 2020 |
| Covidien LP | 2 | $30,000 | 2020 |
| B. Braun Medical Inc. | 1 | $30,000 | 2020 |
| Insulet Corporation | 33 | $28,512 | 2020 |
| Siemens Medical Solutions USA, Inc. | 4 | $20,870 | 2020 |
| Roche Diagnostics Corporation | 4 | $14,266 | 2020 |
| BioFire Diagnostics, LLC | 2 | $9,000 | 2020 |
| Medtronic USA, Inc. | 1 | $6,689 | 2020 |
| Medtronic MiniMed, Inc. | 4 | $6,400 | 2020 |
| Stryker Corporation | 17 | $3,402 | 2020 |
| Orthofix Medical, Inc. | 1 | $2,860 | 2020 |
| Celgene Corporation | 1 | $1,520 | 2020 |
| Arbor Pharmaceuticals, Inc. | 6 | $1,102 | 2020 |
| Luminex Molecular Diagnostics | 1 | $875 | 2020 |
| ACUMED LLC | 1 | $633 | 2020 |
| Linvatec Corporation | 2 | $620 | 2020 |
| KLS-Martin L.P. | 1 | $500 | 2020 |
| Varian Medical Systems, Inc. | 2 | $400 | 2020 |
| Abbott Laboratories | 3 | $150 | 2020 |
| Oticon Medical, LLC | 1 | $74 | 2020 |
| EMD Millipore Corporation | 1 | $35 | 2020 |
| Olympus America Inc. | 1 | $22 | 2020 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Research payment | 64 | $603,493 |
| Grant | 6 | $41,620 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 54 | $38,414 |
| Charitable Contribution | 3 | $30,760 |
| Education | 4 | $9,601 |
| Consulting Fee | 4 | $8,000 |
| Space rental or facility fees (teaching hospital only) | 1 | $6,689 |
| Gift | 8 | $1,125 |
| Honoraria | 1 | $875 |
| Royalty or License | 1 | $35 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2020-12-31 | Siemens Medical Solutions USA, Inc. | $9,493 | Research payment | Cash or cash equivalent | GEISINGER2018MRIPR887923926Fielden | 2020 | |
| 2020-12-31 | Siemens Medical Solutions USA, Inc. | $750 | Research payment | Cash or cash equivalent | Geisinger2019MRIPR724Haggerty | 2020 | |
| 2020-12-31 | Linvatec Corporation | $511 | Grant | In-kind items and services | MICROPOWER Device, ORTHOPEDIC SURGERY | 2020 | |
| 2020-12-31 | Siemens Medical Solutions USA, Inc. | $127 | Charitable Contribution | In-kind items and services | 2020 | ||
| 2020-12-31 | Abbott Laboratories | $30 | Research payment | In-kind items and services | Agilis HisPro Device, Cardiac Arrhythmias and Heart Failure | Physiologic Pacing Registry | 2020 |
| 2020-12-31 | Abbott Laboratories | $20 | Research payment | In-kind items and services | Agilis HisPro Device, Cardiac Arrhythmias and Heart Failure | Physiologic Pacing Registry | 2020 |
| 2020-12-31 | Stryker Corporation | $0 | Gift | Cash or cash equivalent | NONE Device, NONE | 2020 | |
| 2020-12-24 | Arbor Pharmaceuticals, Inc. | $157 | Gift | In-kind items and services | Nymalize Drug, Neurology | 2020 | |
| 2020-12-22 | Novo Nordisk AS | $7,167 | Research payment | Cash or cash equivalent | EX9536-4388 | 2020 | |
| 2020-12-22 | Insulet Corporation | $704 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v (2 payments) | Cash or cash equivalent | Omnipod Device, Insulin Pump | 2020 | |
| 2020-12-19 | Novo Nordisk Inc | $181,970 | Research payment | Cash or cash equivalent | HEOR-Geisinger-Williams | 2020 | |
| 2020-12-18 | Medtronic MiniMed, Inc. | $1,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Minimed 670G System Device, Durable Pump | 2020 | |
| 2020-12-17 | Insulet Corporation | $352 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Omnipod Device, Insulin Pump | 2020 | |
| 2020-12-17 | Arbor Pharmaceuticals, Inc. | $315 | Gift | In-kind items and services | Nymalize Drug, Neurology | 2020 | |
| 2020-12-09 | Insulet Corporation | $2,464 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v (7 payments) | Cash or cash equivalent | Omnipod Device, Insulin Pump | 2020 | |
| 2020-12-02 | Insulet Corporation | $704 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v (2 payments) | Cash or cash equivalent | Omnipod Device, Insulin Pump | 2020 | |
| 2020-12-02 | Arbor Pharmaceuticals, Inc. | $157 | Gift | In-kind items and services | Nymalize Drug, Neurology | 2020 | |
| 2020-11-25 | Arbor Pharmaceuticals, Inc. | $157 | Gift | In-kind items and services | Nymalize Drug, Neurology | 2020 | |
| 2020-11-24 | Novo Nordisk AS | $49 | Research payment | In-kind items and services | EX9536-4388 | 2020 | |
| 2020-11-18 | Arbor Pharmaceuticals, Inc. | $157 | Gift | In-kind items and services | Nymalize Drug, Neurology | 2020 | |
| 2020-11-16 | Covidien LP | $10,000 | Grant | Cash or cash equivalent | 2020 | ||
| 2020-11-16 | Oticon Medical, LLC | $74 | Education (3 payments) | Cash or cash equivalent | PONTO BONE ANCHORED HEARING SYSTEM Device, Medical Device | 2020 | |
| 2020-11-12 | Insulet Corporation | $352 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Omnipod Device, Insulin Pump | 2020 | |
| 2020-11-12 | CSL Behring | $267 | Research payment | Cash or cash equivalent | A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy a | 2020 | |
| 2020-11-12 | Arbor Pharmaceuticals, Inc. | $157 | Gift | In-kind items and services | Nymalize Drug, Neurology | 2020 | |
| 2020-11-04 | Insulet Corporation | $1,408 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v (4 payments) | Cash or cash equivalent | Omnipod Device, Insulin Pump | 2020 | |
| 2020-10-29 | Novo Nordisk AS | $22,817 | Research payment | Cash or cash equivalent | NN9931-4296 | 2020 | |
| 2020-10-29 | Novo Nordisk AS | $2,215 | Research payment | Cash or cash equivalent | EX9536-4388 | 2020 | |
| 2020-10-29 | Novo Nordisk AS | $1,000 | Research payment | Cash or cash equivalent | NN9931-4296 | 2020 | |
| 2020-10-29 | Novo Nordisk AS | $1,000 | Research payment | Cash or cash equivalent | NN9931-4296 | 2020 | |
| 2020-10-29 | Novo Nordisk AS | $1,000 | Research payment | Cash or cash equivalent | NN9931-4296 | 2020 | |
| 2020-10-29 | Novo Nordisk AS | $500 | Research payment | Cash or cash equivalent | NN9931-4296 | 2020 | |
| 2020-10-29 | Novo Nordisk AS | $384 | Research payment | Cash or cash equivalent | EX9536-4388 | 2020 | |
| 2020-10-27 | B. Braun Medical Inc. | $30,000 | Charitable Contribution | Cash or cash equivalent | 2020 | ||
| 2020-10-22 | Insulet Corporation | $352 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Omnipod Device, Insulin Pump | 2020 | |
| 2020-10-15 | Insulet Corporation | $704 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v (2 payments) | Cash or cash equivalent | Omnipod Device, Insulin Pump | 2020 | |
| 2020-10-13 | Stryker Corporation | $660 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES | 2020 | |
| 2020-10-13 | Stryker Corporation | $281 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES | 2020 | |
| 2020-10-13 | Stryker Corporation | $90 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES | 2020 | |
| 2020-10-13 | Stryker Corporation | $44 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES | 2020 | |
| 2020-10-08 | Merck Sharp & Dohme LLC | $20 | Research payment | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | A Randomized, Double-Blind, Phase III Study of Pembrolizumab versus Placebo in Combination with Neoadjuvant Chemotherapy | 2020 |
| 2020-10-07 | Insulet Corporation | $704 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v (2 payments) | Cash or cash equivalent | Omnipod Device, Insulin Pump | 2020 | |
| 2020-10-07 | Varian Medical Systems, Inc. | $200 | Consulting Fee | Cash or cash equivalent | OTHER Device, Devices | 2020 | |
| 2020-10-06 | CSL Behring | $810 | Research payment | Cash or cash equivalent | A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy a | 2020 | |
| 2020-10-06 | CSL Behring | $267 | Research payment | Cash or cash equivalent | A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy a | 2020 | |
| 2020-09-30 | Siemens Medical Solutions USA, Inc. | $10,500 | Grant | In-kind items and services | 2020 | ||
| 2020-09-28 | Medtronic MiniMed, Inc. | $1,950 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Minimed 670G System Device, Durable Pump | 2020 | |
| 2020-09-24 | Insulet Corporation | $352 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Omnipod Device, Insulin Pump | 2020 | |
| 2020-09-16 | Insulet Corporation | $704 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v (2 payments) | Cash or cash equivalent | Omnipod Device, Insulin Pump | 2020 | |
| 2020-09-08 | Merck Sharp & Dohme LLC | $29 | Research payment | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | A Randomized, Double-Blind, Phase III Study of Pembrolizumab versus Placebo in Combination with Neoadjuvant Chemotherapy | 2020 |
| 2020-09-08 | Merck Sharp & Dohme LLC | $29 | Research payment | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | A Randomized, Double-Blind, Phase III Study of Pembrolizumab versus Placebo in Combination with Neoadjuvant Chemotherapy | 2020 |
| 2020-09-08 | Merck Sharp & Dohme LLC | $29 | Research payment | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | A Randomized, Double-Blind, Phase III Study of Pembrolizumab versus Placebo in Combination with Neoadjuvant Chemotherapy | 2020 |
| 2020-09-08 | Merck Sharp & Dohme LLC | $29 | Research payment | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | A Randomized, Double-Blind, Phase III Study of Pembrolizumab versus Placebo in Combination with Neoadjuvant Chemotherapy | 2020 |
| 2020-09-08 | Merck Sharp & Dohme LLC | $29 | Research payment | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | A Randomized, Double-Blind, Phase III Study of Pembrolizumab versus Placebo in Combination with Neoadjuvant Chemotherapy | 2020 |
| 2020-09-08 | Merck Sharp & Dohme LLC | $29 | Research payment | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | A Randomized, Double-Blind, Phase III Study of Pembrolizumab versus Placebo in Combination with Neoadjuvant Chemotherapy | 2020 |
| 2020-09-08 | Merck Sharp & Dohme LLC | $29 | Research payment | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | A Randomized, Double-Blind, Phase III Study of Pembrolizumab versus Placebo in Combination with Neoadjuvant Chemotherapy | 2020 |
| 2020-09-03 | Insulet Corporation | $1,056 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v (3 payments) | Cash or cash equivalent | Omnipod Device, Insulin Pump | 2020 | |
| 2020-08-31 | Insulet Corporation | $352 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Omnipod Device, Insulin Pump | 2020 | |
| 2020-08-27 | JAZZ PHARMACEUTICALS INC. | $71,541 | Research payment | In-kind items and services | XYWAV Drug, NEUROLOGY | JZP080-301 A DOUBLE-BLIND, PLACEBO-CONTROLLED, RAMDOMIZED WITHDRAWAL, MULTICENTER STUDY OF THE EFFICACY AND SAFETY OF JZ | 2020 |
| 2020-08-27 | JAZZ PHARMACEUTICALS INC. | $30,660 | Research payment | In-kind items and services | XYWAV Drug, NEUROLOGY | JZP080-301 A DOUBLE-BLIND, PLACEBO-CONTROLLED, RAMDOMIZED WITHDRAWAL, MULTICENTER STUDY OF THE EFFICACY AND SAFETY OF JZ | 2020 |
| 2020-08-21 | Insulet Corporation | $352 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Omnipod Device, Insulin Pump | 2020 | |
| 2020-08-13 | Orthofix Medical, Inc. | $2,860 | Education | Cash or cash equivalent | 2020 | ||
| 2020-08-12 | Insulet Corporation | $352 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Omnipod Device, Insulin Pump | 2020 | |
| 2020-08-11 | CSL Behring | $1,528 | Research payment | Cash or cash equivalent | A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy a | 2020 | |
| 2020-08-10 | Merck Sharp & Dohme LLC | $247 | Research payment | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | A Randomized, Double-Blind, Phase III Study of Pembrolizumab versus Placebo in Combination with Neoadjuvant Chemotherapy | 2020 |
| 2020-08-10 | Merck Sharp & Dohme LLC | $20 | Research payment | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | A Randomized, Double-Blind, Phase III Study of Pembrolizumab versus Placebo in Combination with Neoadjuvant Chemotherapy | 2020 |
| 2020-08-06 | Insulet Corporation | $1,056 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v (3 payments) | Cash or cash equivalent | Omnipod Device, Insulin Pump | 2020 | |
| 2020-08-05 | Novo Nordisk Inc | $20,000 | Research payment | Cash or cash equivalent | HEOR-Geisinger-Still | 2020 | |
| 2020-07-30 | Novo Nordisk AS | $2,261 | Research payment | Cash or cash equivalent | EX9536-4388 | 2020 | |
| 2020-07-30 | Insulet Corporation | $704 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v (2 payments) | Cash or cash equivalent | Omnipod Device, Insulin Pump | 2020 | |
| 2020-07-30 | Novo Nordisk AS | $540 | Research payment | Cash or cash equivalent | EX9536-4388 | 2020 | |
| 2020-07-29 | Varian Medical Systems, Inc. | $200 | Consulting Fee | Cash or cash equivalent | Halcyon Device, Devices | 2020 | |
| 2020-07-15 | Insulet Corporation | $352 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Omnipod Device, Insulin Pump | 2020 | |
| 2020-07-09 | CSL Behring | $1,528 | Research payment | Cash or cash equivalent | A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy a | 2020 | |
| 2020-07-09 | CSL Behring | $267 | Research payment | Cash or cash equivalent | A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy a | 2020 | |
| 2020-07-06 | Novo Nordisk Inc | $22,679 | Research payment | Cash or cash equivalent | HEOR-Geisinger-Still | 2020 | |
| 2020-07-06 | Stryker Corporation | $272 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES | 2020 | |
| 2020-07-06 | Stryker Corporation | $97 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES | 2020 | |
| 2020-07-06 | Stryker Corporation | $27 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES | 2020 | |
| 2020-07-06 | Stryker Corporation | $11 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES | 2020 | |
| 2020-07-01 | Insulet Corporation | $2,112 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v (6 payments) | Cash or cash equivalent | Omnipod Device, Insulin Pump | 2020 | |
| 2020-06-23 | Novo Nordisk AS | $820 | Research payment | Cash or cash equivalent | EX9536-4388 | 2020 | |
| 2020-06-22 | Insulet Corporation | $1,056 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v (3 payments) | Cash or cash equivalent | Omnipod Device, Insulin Pump | 2020 | |
| 2020-06-16 | Medtronic MiniMed, Inc. | $500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Minimed 670G System Device, Durable Pump | 2020 | |
| 2020-06-10 | Insulet Corporation | $352 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Omnipod Device, Insulin Pump | 2020 | |
| 2020-06-04 | CSL Behring | $764 | Research payment | Cash or cash equivalent | A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy a | 2020 | |
| 2020-05-27 | Insulet Corporation | $704 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v (2 payments) | Cash or cash equivalent | Omnipod Device, Insulin Pump | 2020 | |
| 2020-05-15 | Covidien LP | $20,000 | Grant | Cash or cash equivalent | 2020 | ||
| 2020-05-14 | CSL Behring | $1,869 | Research payment | Cash or cash equivalent | A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy a | 2020 | |
| 2020-05-07 | Novo Nordisk Inc | $60,657 | Research payment | Cash or cash equivalent | HEOR-Geisinger-Williams | 2020 | |
| 2020-05-07 | Insulet Corporation | $1,408 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v (4 payments) | Cash or cash equivalent | Omnipod Device, Insulin Pump | 2020 | |
| 2020-05-05 | Roche Diagnostics Corporation | $1,800 | Consulting Fee | Cash or cash equivalent | CD cobas Automation Device, Centralized Diagnostics | 2020 | |
| 2020-05-01 | Stryker Corporation | $783 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES | 2020 | |
| 2020-05-01 | Stryker Corporation | $305 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES | 2020 | |
| 2020-05-01 | Stryker Corporation | $105 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES | 2020 | |
| 2020-05-01 | Stryker Corporation | $49 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES | 2020 | |
| 2020-04-30 | ACUMED LLC | $633 | Charitable Contribution | In-kind items and services | 2020 | ||
| 2020-04-30 | Novo Nordisk AS | $72 | Research payment | In-kind items and services | NN9931-4296 | 2020 | |
| 2020-04-29 | Insulet Corporation | $704 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v (2 payments) | Cash or cash equivalent | Omnipod Device, Insulin Pump | 2020 | |
| 2020-04-24 | Insulet Corporation | $1,760 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v (5 payments) | Cash or cash equivalent | Omnipod Device, Insulin Pump | 2020 | |
| 2020-04-14 | CSL Behring | $50 | Research payment | Cash or cash equivalent | A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy a | 2020 | |
| 2020-04-14 | CSL Behring | $50 | Research payment | Cash or cash equivalent | A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy a | 2020 | |
| 2020-04-09 | CSL Behring | $943 | Research payment | Cash or cash equivalent | A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy a | 2020 | |
| 2020-04-09 | CSL Behring | $832 | Research payment | Cash or cash equivalent | A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy a | 2020 | |
| 2020-04-08 | Insulet Corporation | $1,056 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v (3 payments) | Cash or cash equivalent | Omnipod Device, Insulin Pump | 2020 | |
| 2020-04-02 | Insulet Corporation | $704 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v (2 payments) | Cash or cash equivalent | Omnipod Device, Insulin Pump | 2020 | |
| 2020-04-01 | BioFire Diagnostics, LLC | $4,500 | Research payment | In-kind items and services | FilmArray System Device, Clinical Diagnostics | FilmArray BJI Pivotal Study | 2020 |
| 2020-04-01 | BioFire Diagnostics, LLC | $4,500 | Research payment | In-kind items and services | FilmArray System Device, Clinical Diagnostics | FilmArray BJI Pivotal Study | 2020 |
| 2020-03-18 | Luminex Molecular Diagnostics | $875 | Honoraria | In-kind items and services | ARIES Device, Device | 2020 | |
| 2020-03-18 | Insulet Corporation | $352 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Omnipod Device, Insulin Pump | 2020 | |
| 2020-03-17 | Medtronic MiniMed, Inc. | $2,150 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Minimed 670G System Device, Durable Pump | 2020 | |
| 2020-03-12 | CSL Behring | $7,428 | Research payment | Cash or cash equivalent | A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy a | 2020 | |
| 2020-03-12 | CSL Behring | $300 | Research payment | Cash or cash equivalent | A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy a | 2020 | |
| 2020-03-12 | CSL Behring | $270 | Research payment | Cash or cash equivalent | A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy a | 2020 | |
| 2020-03-04 | Merck Sharp & Dohme LLC | $16,239 | Research payment | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | A Randomized, Double-Blind, Phase III Study of Pembrolizumab versus Placebo in Combination with Neoadjuvant Chemotherapy | 2020 |
| 2020-03-04 | Abbott Laboratories | $100 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2020 | ||
| 2020-03-02 | OpGen, Inc. | $44,275 | Research payment | Cash or cash equivalent | Acuitas AMR Gene Panel u5.47 Urine Clinical Performance Evaluation | 2020 | |
| 2020-03-02 | JAZZ PHARMACEUTICALS INC. | $12 | Research payment | Cash or cash equivalent | XYWAV Drug, NEUROLOGY | A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED WITHDRAWAL, MULTICENTER STUDY OF THE EFFICACY AND SAFETY OF JZP-258 IN TH | 2020 |
| 2020-03-02 | JAZZ PHARMACEUTICALS INC. | $2 | Research payment | Cash or cash equivalent | XYWAV Drug, NEUROLOGY | A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED WITHDRAWAL, MULTICENTER STUDY OF THE EFFICACY AND SAFETY OF JZP-258 IN TH | 2020 |
| 2020-02-29 | Roche Diagnostics Corporation | $3,333 | Education | In-kind items and services | DIS Navify Software Device, Diagnostic Information Solutions | 2020 | |
| 2020-02-26 | Medtronic USA, Inc. | $6,689 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | CD HORIZON Device, TL | 2020 | |
| 2020-02-26 | KLS-Martin L.P. | $500 | Grant | Cash or cash equivalent | 2020 | ||
| 2020-02-26 | Insulet Corporation | $352 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Omnipod Device, Insulin Pump | 2020 | |
| 2020-02-26 | EMD Millipore Corporation | $35 | Royalty or License | Cash or cash equivalent | Device, DIAGNOSTIC TESTING | 2020 | |
| 2020-02-13 | CSL Behring | $8,603 | Research payment | Cash or cash equivalent | A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy a | 2020 | |
| 2020-02-13 | CSL Behring | $150 | Research payment | Cash or cash equivalent | A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy a | 2020 | |
| 2020-02-11 | Merck Sharp & Dohme LLC | $16,239 | Research payment | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | A Randomized, Double-Blind, Phase III Study of Pembrolizumab versus Placebo in Combination with Neoadjuvant Chemotherapy | 2020 |
| 2020-02-11 | Celgene Corporation | $1,520 | Research payment | Cash or cash equivalent | Revlimid Drug, Hematology | Celgene - Connect MM | 2020 |
| 2020-02-03 | JAZZ PHARMACEUTICALS INC. | $32 | Research payment | Cash or cash equivalent | XYWAV Drug, NEUROLOGY | A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED WITHDRAWAL, MULTICENTER STUDY OF THE EFFICACY AND SAFETY OF JZP-258 IN TH | 2020 |
| 2020-01-31 | Roche Diagnostics Corporation | $3,333 | Education | In-kind items and services | DIS Navify Software Device, Diagnostic Information Solutions | 2020 | |
| 2020-01-30 | Roche Diagnostics Corporation | $5,800 | Consulting Fee | Cash or cash equivalent | CD cobas Automation Device, Centralized Diagnostics | 2020 | |
| 2020-01-29 | Insulet Corporation | $352 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Omnipod Device, Insulin Pump | 2020 | |
| 2020-01-28 | Olympus America Inc. | $22 | Gift | In-kind items and services | OER Pro Accessories Device, GI & Respiratory Products | 2020 | |
| 2020-01-27 | Insulet Corporation | $704 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v (2 payments) | Cash or cash equivalent | Omnipod Device, Insulin Pump | 2020 | |
| 2020-01-24 | Linvatec Corporation | $108 | Grant | In-kind items and services | HALL POWER Device, ORTHOPEDIC SURGERY | 2020 | |
| 2020-01-14 | Stryker Corporation | $428 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES | 2020 | |
| 2020-01-14 | Stryker Corporation | $171 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES | 2020 | |
| 2020-01-14 | Stryker Corporation | $49 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES | 2020 | |
| 2020-01-14 | Stryker Corporation | $23 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES | 2020 | |
| 2020-01-13 | Novo Nordisk Inc | $40,000 | Research payment | Cash or cash equivalent | 10yrs + relationship b/n long-term weight maintenance, clinical relevance & healthcare utilization? | 2020 | |
| 2020-01-09 | CSL Behring | $10,877 | Research payment | Cash or cash equivalent | A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy a | 2020 | |
| 2020-01-09 | CSL Behring | $837 | Research payment | Cash or cash equivalent | A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy a | 2020 | |
| 2020-01-09 | CSL Behring | $350 | Research payment | Cash or cash equivalent | A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy a | 2020 | |
| 2020-01-09 | CSL Behring | $50 | Research payment | Cash or cash equivalent | A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy a | 2020 | |
| 2020-01-08 | Insulet Corporation | $352 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Omnipod Device, Insulin Pump | 2020 | |
| 2020-01-03 | Insulet Corporation | $3,520 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v (10 payments) | Cash or cash equivalent | Omnipod Device, Insulin Pump | 2020 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Danville, PA, county Montour County, PA, state Pennsylvania; placed by its city name.
| Measure | Place (city or town) Danville, PA | County Montour County, PA | State Pennsylvania |
|---|---|---|---|
| Population B01003 | 4,217 | 18,103 | 13,018,639 |
| Population, 2020 census P1 | 4,239 | 18,136 | 13,002,700 |
| Median age B01002 | 38.6 | 42.9 | 40.9 |
| Under 18 B01001 | 19.0% | 20.1% | 20.4% |
| 65 and over B01001 | 24.9% | 21.8% | 19.5% |
| Households B11001 | 2,338 | 7,862 | 5,274,853 |
| Foreign born B05002 | 3.8% | 5.6% | 7.7% |
| Median household income B19013 | $59,219 | $76,976 | $77,971 |
| Median family income B19113 | $78,077 | $93,140 | $100,262 |
| Per capita income B19301 | $40,050 | $46,827 | $44,355 |
| Poverty rate B17001 | 14.0% | 8.8% | 11.7% |
| Unemployment rate B23025 | 3.7% | 2.9% | 5.3% |
| Civilian labor force B23025 | 1,997 | 8,736 | 6,684,175 |
| Mean commute (minutes) B08013 | 11.6 | 19.4 | 26.3 |
| Bachelor's degree or higher B15003 | 44.0% | 38.7% | 35.2% |
| Housing units B25001 | 2,488 | 8,144 | 5,806,452 |
| Owner-occupied B25003 | 42.7% | 68.5% | 69.3% |
| Renters B25003 | 57.3% | 31.5% | 30.7% |
| Median home value B25077 | $186,400 | $248,100 | $254,500 |
| Median gross rent B25064 | $1,105 | $1,142 | $1,209 |
| White, not Hispanic B03002 | 88.3% | 89.0% | 73.0% |
| Black B03002 | 3.0% | 2.4% | 10.3% |
| Hispanic or Latino B03002 | 4.3% | 3.1% | 8.7% |
| Asian B03002 | 3.8% | 3.4% | 3.8% |
| American Indian and Alaska Native B03002 | 0.0% | 0.0% | 0.1% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Danville, PA.
Comments